Brooklyn Investment Group’s Novo Nordisk NVO Stock Holding History

Brooklyn Investment Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.44M	Sell	93,638 -3,194	-3%	-$151K	0.11%	150
2025 Q4	$4.98M	Buy	96,832 +63,580	+191%	+$3.25M	0.23%	73
2025 Q3	$2.28M	Sell	33,252 -177	-0.5%	-$10.4K	0.31%	58
2025 Q2	$2.31M	Buy	33,429 +19,010	+132%	+$1.29M	0.3%	60
2025 Q1	$1M	Buy	14,419 +11,488	+392%	+$949K	0.22%	93
2024 Q4	$252K	Buy	2,931 +2,762	+1,634%	+$299K	0.08%	215
2024 Q3	$20.1K	Buy	+169	New	+$22.5K	0.01%	647

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Brooklyn Investment Group's NVO Position: Q1 2026 in Review

Brooklyn Investment Group reduced its Novo Nordisk (NVO) stake by 3.3% in Q1 2026, selling an estimated $151K and leaving 93,638 shares worth $3.44M. The position accounts for 0.11% of the portfolio, ranked #150.

Brooklyn Investment Group first reported a position in NVO in Q3 2024 and has held it in 7 quarters since. The position peaked at $4.98M in Q4 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Brooklyn Investment Group held 93,638 shares of Novo Nordisk worth $3.44M as of Q1 2026.
Brooklyn Investment Group sold 3,194 Novo Nordisk shares in Q1 2026, an estimated $151K.
Novo Nordisk made up 0.11% of Brooklyn Investment Group's portfolio in Q1 2026, its #150 holding.
Brooklyn Investment Group first reported a position in Novo Nordisk in Q3 2024 and has held it in 7 quarters since.
Brooklyn Investment Group's Novo Nordisk position peaked at $4.98M in Q4 2025.
1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.